eskymaks/iStock via Getty Images Listen here or on the go via Apple Podcasts and Spotify    Analyst Alex Carchidi discusses positive news coming out of psychedelic space (1:00). Recent earnings show companies moving closer to commercialization (3:35). Cybin and Atai developments; clinical studies and regulatory relief (5:25). Why now is the time to get into the space; ranking Compass and MindMed above the rest (8:00). Proper metrics and diversified pipelines (10:20). Transcript Rena Sherbill: Alex Carch ...